221 related articles for article (PubMed ID: 28342860)
1. Functional characterization of lysophosphatidic acid receptor 1 mutants identified in rat cancer tissues.
Ishii S; Tsujiuchi T; Fukushima N
Biochem Biophys Res Commun; 2017 May; 486(3):767-773. PubMed ID: 28342860
[TBL] [Abstract][Full Text] [Related]
2. Lysophosphatidylethanolamine utilizes LPA(1) and CD97 in MDA-MB-231 breast cancer cells.
Park SJ; Lee KP; Kang S; Chung HY; Bae YS; Okajima F; Im DS
Cell Signal; 2013 Nov; 25(11):2147-54. PubMed ID: 23838008
[TBL] [Abstract][Full Text] [Related]
3. Anatomical location of LPA1 activation and LPA phospholipid precursors in rodent and human brain.
González de San Román E; Manuel I; Giralt MT; Chun J; Estivill-Torrús G; Rodríguez de Fonseca F; Santín LJ; Ferrer I; Rodríguez-Puertas R
J Neurochem; 2015 Aug; 134(3):471-85. PubMed ID: 25857358
[TBL] [Abstract][Full Text] [Related]
4. Antidepressants activate the lysophosphatidic acid receptor LPA(1) to induce insulin-like growth factor-I receptor transactivation, stimulation of ERK1/2 signaling and cell proliferation in CHO-K1 fibroblasts.
Olianas MC; Dedoni S; Onali P
Biochem Pharmacol; 2015 Jun; 95(4):311-23. PubMed ID: 25888927
[TBL] [Abstract][Full Text] [Related]
5. Cross-talk between lysophosphatidic acid receptor 1 and tropomyosin receptor kinase A promotes lung epithelial cell migration.
Nan L; Wei J; Jacko AM; Culley MK; Zhao J; Natarajan V; Ma H; Zhao Y
Biochim Biophys Acta; 2016 Feb; 1863(2):229-35. PubMed ID: 26597701
[TBL] [Abstract][Full Text] [Related]
6. LPA signaling is required for dopaminergic neuron development and is reduced through low expression of the LPA1 receptor in a 6-OHDA lesion model of Parkinson's disease.
Yang XY; Zhao EY; Zhuang WX; Sun FX; Han HL; Han HR; Lin ZJ; Pan ZF; Qu MH; Zeng XW; Ding Y
Neurol Sci; 2015 Nov; 36(11):2027-33. PubMed ID: 26169757
[TBL] [Abstract][Full Text] [Related]
7. Lysophosphatidic acid signaling via LPA
Fukushima K; Takahashi K; Yamasaki E; Onishi Y; Fukushima N; Honoki K; Tsujiuchi T
Exp Cell Res; 2017 Mar; 352(1):139-145. PubMed ID: 28189636
[TBL] [Abstract][Full Text] [Related]
8. A blocking peptide stabilizes lysophosphatidic acid receptor 1 and promotes lysophosphatidic acid-induced cellular responses.
Taleb SJ; Wei J; Mialki RK; Dong S; Li Y; Zhao J; Zhao Y
J Cell Biochem; 2021 Aug; 122(8):827-834. PubMed ID: 33847006
[TBL] [Abstract][Full Text] [Related]
9. Lysophosphatidic acid (LPA) signaling via LPA
Takahashi K; Fukushima K; Onishi Y; Inui K; Node Y; Fukushima N; Honoki K; Tsujiuchi T
Biochem Biophys Res Commun; 2017 Jan; 483(1):652-657. PubMed ID: 27993681
[TBL] [Abstract][Full Text] [Related]
10. Lys39-Lysophosphatidate Carbonyl Oxygen Interaction Locks LPA1 N-terminal Cap to the Orthosteric Site and partners Arg124 During Receptor Activation.
Omotuyi OI; Nagai J; Ueda H
Sci Rep; 2015 Aug; 5():13343. PubMed ID: 26268898
[TBL] [Abstract][Full Text] [Related]
11. Structural insights into ligand recognition by the lysophosphatidic acid receptor LPA
Taniguchi R; Inoue A; Sayama M; Uwamizu A; Yamashita K; Hirata K; Yoshida M; Tanaka Y; Kato HE; Nakada-Nakura Y; Otani Y; Nishizawa T; Doi T; Ohwada T; Ishitani R; Aoki J; Nureki O
Nature; 2017 Aug; 548(7667):356-360. PubMed ID: 28792932
[TBL] [Abstract][Full Text] [Related]
12. Lysophosphatidic Acid Signaling through the Lysophosphatidic Acid-1 Receptor Is Required for Alveolarization.
Funke M; Knudsen L; Lagares D; Ebener S; Probst CK; Fontaine BA; Franklin A; Kellner M; Kühnel M; Matthieu S; Grothausmann R; Chun J; Roberts JD; Ochs M; Tager AM
Am J Respir Cell Mol Biol; 2016 Jul; 55(1):105-16. PubMed ID: 27082727
[TBL] [Abstract][Full Text] [Related]
13. Effects of LPA
Takahashi K; Fukushima K; Otagaki S; Ishimoto K; Minami K; Fukushima N; Honoki K; Tsujiuchi T
J Recept Signal Transduct Res; 2018 Feb; 38(1):71-75. PubMed ID: 29369010
[TBL] [Abstract][Full Text] [Related]
14. The LPA1/ZEB1/miR-21-activation pathway regulates metastasis in basal breast cancer.
Sahay D; Leblanc R; Grunewald TG; Ambatipudi S; Ribeiro J; Clézardin P; Peyruchaud O
Oncotarget; 2015 Aug; 6(24):20604-20. PubMed ID: 26098771
[TBL] [Abstract][Full Text] [Related]
15. Lysophosphatidic Acid Inhibits Insulin Signaling in Primary Rat Hepatocytes via the LPA3 Receptor Subtype and is Increased in Obesity.
Fayyaz S; Japtok L; Schumacher F; Wigger D; Schulz TJ; Haubold K; Gulbins E; Völler H; Kleuser B
Cell Physiol Biochem; 2017; 43(2):445-456. PubMed ID: 28922661
[TBL] [Abstract][Full Text] [Related]
16. LPA-induced migration of ovarian cancer cells requires activation of ERM proteins via LPA
Park J; Jang JH; Oh S; Kim M; Shin C; Jeong M; Heo K; Park JB; Kim SR; Oh YS
Cell Signal; 2018 Apr; 44():138-147. PubMed ID: 29329782
[TBL] [Abstract][Full Text] [Related]
17. Endogenous lysophosphatidic acid (LPA
Sattikar A; Dowling MR; Rosethorne EM
Br J Pharmacol; 2017 Feb; 174(3):227-237. PubMed ID: 27864940
[TBL] [Abstract][Full Text] [Related]
18. Lysophosphatidic acid and its receptor LPA
Srikanth M; Chew WS; Hind T; Lim SM; Hay NWJ; Lee JHM; Rivera R; Chun J; Ong WY; Herr DR
Eur J Pharmacol; 2018 Dec; 841():49-56. PubMed ID: 30321532
[TBL] [Abstract][Full Text] [Related]
19. Positive and Negative Cross-Talk between Lysophosphatidic Acid Receptor 1, Free Fatty Acid Receptor 4, and Epidermal Growth Factor Receptor in Human Prostate Cancer Cells.
Hopkins MM; Liu Z; Meier KE
J Pharmacol Exp Ther; 2016 Oct; 359(1):124-33. PubMed ID: 27474750
[TBL] [Abstract][Full Text] [Related]
20. Lysophosphatidic acid receptor
Hoshino Y; Okuno T; Saigusa D; Kano K; Yamamoto S; Shindou H; Aoki J; Uchida K; Yokomizo T; Ito N
FASEB J; 2022 Apr; 36(4):e22236. PubMed ID: 35218596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]